CervoMed Files Administrative 8-K; No Major News
Ticker: CRVO · Form: 8-K · Filed: Jan 5, 2024 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Jan 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: administrative, corporate-governance, 8-k
TL;DR
**CervoMed's 8-K is just a routine update, nothing to trade on.**
AI Summary
CervoMed Inc. filed an 8-K on January 5, 2024, to report an "Other Event" and provide "Financial Statements and Exhibits." This filing primarily serves to update the public record with basic company information, including its current name, address (20 Park Plaza, Suite 424, Boston, Massachusetts 02216), and contact number ((617) 744-4400). For investors, this filing is largely administrative and doesn't signal any immediate operational changes or financial impacts, meaning it's unlikely to cause significant stock movement.
Why It Matters
This filing is mostly administrative, updating basic company information. It doesn't contain new financial results, strategic announcements, or material events that would typically impact the stock price.
Risk Assessment
Risk Level: low — This 8-K filing is purely administrative and does not disclose any events that would introduce new risks or change the company's operational outlook.
Analyst Insight
A smart investor would recognize this 8-K as a routine administrative filing with no material news. No immediate action is warranted based solely on this document; further research into the company's core business and financial performance would be necessary for investment decisions.
Key Players & Entities
- CervoMed Inc. (company) — the registrant filing the 8-K
- 001-37942 (other) — Commission File Number
- 30-0645032 (other) — I.R.S. Employer Identification No.
- 20 Park Plaza, Suite 424 Boston, Massachusetts 02216 (other) — Address of principal executive offices
- (617) 744-4400 (other) — Registrant’s telephone number
- January 5, 2024 (other) — Date of Report (Date of earliest event reported)
FAQ
What is the purpose of this 8-K filing by CervoMed Inc.?
This 8-K filing by CervoMed Inc. is a Current Report filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934, reporting an "Other Event" and providing "Financial Statements and Exhibits." It primarily serves to update basic company information as of January 5, 2024.
What is CervoMed Inc.'s current business address and phone number, according to the filing?
According to the filing, CervoMed Inc.'s current business address is 20 Park Plaza, Suite 424, Boston, Massachusetts 02216, and its telephone number is (617) 744-4400.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 5, 2024, which is also the Date of Report.
What is CervoMed Inc.'s state of incorporation and Commission File Number?
CervoMed Inc. is incorporated in Delaware, and its Commission File Number is 001-37942.
Does this 8-K filing indicate any significant changes in CervoMed Inc.'s operations or financial status?
No, this 8-K filing does not indicate any significant changes in CervoMed Inc.'s operations or financial status. It is an administrative filing categorized under "Other Events" and "Financial Statements and Exhibits," primarily updating company details rather than announcing material operational or financial developments.
Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-01-05 16:05:35
Key Financial Figures
- $0.001 — on which registered Common Stock , $0.001 par value   CRVO   NAS
Filing Documents
- crvo20240105_8k.htm (8-K) — 23KB
- ex_612618.htm (EX-99.1) — 6KB
- a01.jpg (GRAPHIC) — 7KB
- 0001437749-24-000738.txt ( ) — 169KB
- crvo-20240105.xsd (EX-101.SCH) — 3KB
- crvo-20240105_def.xml (EX-101.DEF) — 11KB
- crvo-20240105_lab.xml (EX-101.LAB) — 15KB
- crvo-20240105_pre.xml (EX-101.PRE) — 11KB
- crvo20240105_8k_htm.xml (XML) — 2KB
01           Other Events
Item 8.01           Other Events   On January 5, 2024, CervoMed Inc. (the "Company") issued a press release announcing that members of the Company's senior management team will present at the Emerging Growth Conference 66 on Thursday, January 11, 2024 at 11:25 a.m. ET. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.  
01           Financial Statements and Exhibits
Item 9.01           Financial Statements and Exhibits   (d)           Exhibits   Exhibit No.   Description       99.1   Press Release issued January 5, 2024 104   Cover Page Interactive Data File (embedded within the Inline XBRL document).        
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   Date: January 5, 2024 CervoMed Inc.   By:          /s/ William Elder __________ Name:    William Elder Title:       General Counsel